Price
CHART BY
Frequently asked questions
What is Semler's market capitalization?
The market capitalization of Semler is $356.89M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Semler's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Semler is 7.26. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Semler?
Semler's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.913. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Semler's stock?
Currently, 1 analysts cover Semler's stock, with a consensus target price of $71.00. Analyst ratings provide insights into the stock's expected performance.
What is Semler's revenue over the trailing twelve months?
Over the trailing twelve months, Semler reported a revenue of $56.29M.
What is the EBITDA for Semler?
Semler's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $21.52M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Semler?
Semler has a free cash flow of $24.36M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Semler have, and what sector and industry does it belong to?
Semler employs approximately 79 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Semler's shares?
The free float of Semler is 7.77M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $356.89M
- EPS (TTM)
- $4.913
- Free Float
- 7.77M
- P/E ratio (TTM)
- 7.26
- Revenue (TTM)
- $56.29M
- EBITDA (TTM)
- $21.52M
- Free Cashflow (TTM)
- $24.36M
Pricing
- 1D span
- $35.77$36.62
- 52W span
- $20.90$81.54
Analyst Ratings
The price target is $71.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
- Employees
- 79
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US81684M1045
- Primary Ticker
- SMLR
Knockouts
Finance data from FactSet